During the last 5 years, German researcher Georg Schett has made a reputation for himself as a pioneer in autoimmune illness therapy, displaying that CAR-T remedy could possibly be used to reset sufferers’ immune methods.
He has develop into a scientific adviser de rigueur for the sphere, becoming a member of a half-dozen startup advisory boards.
Now, for the primary time, he’s co-founding a biotech firm. However it has no fast plans to work in CAR-T.
This text is unique to STAT+ subscribers
Unlock this text — plus each day protection and evaluation of the biotech sector — by subscribing to STAT+.
Have already got an account? Log in
View All Plans
